Fifth Third Bancorp Novo Nordisk A S Transaction History

Fifth Third Bancorp

  • $26.1 Billion
  • Q2 2024

A detailed history of Fifth Third Bancorp transactions in Novo Nordisk A S stock. As of the latest transaction made, Fifth Third Bancorp holds 52,984 shares of NVO stock, worth $6.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
52,984
Previous 53,549 1.06%
Holding current value
$6.4 Million
Previous $6.88 Million 9.99%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024
SELL
$122.71 - $146.91 $69,331 - $83,004
-565 Reduced 1.06%
52,984 $7.56 Million
Q1 2024

Apr 23, 2024
SELL
$102.11 - $135.92 $307,248 - $408,983
-3,009 Reduced 5.32%
53,549 $6.88 Million
Q4 2023

Jan 19, 2024
SELL
$87.78 - $105.45 $277,999 - $333,960
-3,167 Reduced 5.3%
56,558 $5.85 Million
Q3 2023

Oct 31, 2023
BUY
$90.94 - $199.54 $2.59 Million - $5.68 Million
28,466 Added 91.06%
59,725 $5.43 Million
Q2 2023

Jul 25, 2023
SELL
$155.98 - $172.65 $1.36 Million - $1.5 Million
-8,700 Reduced 21.77%
31,259 $5.06 Million
Q1 2023

Apr 24, 2023
BUY
$132.34 - $159.14 $39,569 - $47,582
299 Added 0.75%
39,959 $6.36 Million
Q4 2022

Jan 25, 2023
SELL
$102.55 - $135.33 $46,352 - $61,169
-452 Reduced 1.13%
39,660 $0
Q3 2022

Oct 25, 2022
SELL
$95.28 - $116.93 $979,764 - $1.2 Million
-10,283 Reduced 20.4%
40,112 $4 Million
Q2 2022

Aug 04, 2022
SELL
$103.24 - $121.81 $339,659 - $400,754
-3,290 Reduced 6.13%
50,395 $5.62 Million
Q1 2022

Apr 19, 2022
SELL
$93.1 - $112.54 $124,102 - $150,015
-1,333 Reduced 2.42%
53,685 $5.96 Million
Q4 2021

Feb 01, 2022
SELL
$95.88 - $117.08 $370,576 - $452,514
-3,865 Reduced 6.56%
55,018 $6.16 Million
Q3 2021

Oct 15, 2021
SELL
$84.42 - $106.62 $189,100 - $238,828
-2,240 Reduced 3.66%
58,883 $5.65 Million
Q2 2021

Aug 06, 2021
BUY
$67.66 - $84.76 $166,714 - $208,848
2,464 Added 4.2%
61,123 $5.12 Million
Q1 2021

May 07, 2021
BUY
$67.06 - $75.82 $31,115 - $35,180
464 Added 0.8%
58,659 $3.96 Million
Q4 2020

Feb 16, 2021
BUY
$63.89 - $73.8 $130,335 - $150,552
2,040 Added 3.63%
58,195 $4.07 Million
Q3 2020

Nov 09, 2020
SELL
$63.69 - $70.22 $53,117 - $58,563
-834 Reduced 1.46%
56,155 $3.9 Million
Q2 2020

Aug 05, 2020
SELL
$58.54 - $67.94 $18,498 - $21,469
-316 Reduced 0.55%
56,989 $3.73 Million
Q1 2020

May 05, 2020
SELL
$49.46 - $64.78 $59,302 - $77,671
-1,199 Reduced 2.05%
57,305 $3.45 Million
Q4 2019

Feb 14, 2020
SELL
$49.86 - $58.26 $120,461 - $140,756
-2,416 Reduced 3.97%
58,504 $3.39 Million
Q3 2019

Nov 14, 2019
SELL
$47.54 - $53.43 $97,076 - $109,104
-2,042 Reduced 3.24%
60,920 $3.15 Million
Q2 2019

Aug 07, 2019
BUY
$46.79 - $52.47 $92,457 - $103,680
1,976 Added 3.24%
62,962 $3.21 Million
Q1 2019

May 14, 2019
SELL
$46.36 - $52.63 $59,387 - $67,419
-1,281 Reduced 2.06%
60,986 $3.19 Million
Q4 2018

Feb 14, 2019
SELL
$41.54 - $47.25 $39,587 - $45,029
-953 Reduced 1.51%
62,267 $2.87 Million
Q3 2018

Nov 14, 2018
SELL
$46.76 - $51.24 $73,880 - $80,959
-1,580 Reduced 2.44%
63,220 $2.98 Million
Q2 2018

Aug 14, 2018
SELL
$44.29 - $50.42 $110,016 - $125,243
-2,484 Reduced 3.69%
64,800 $2.99 Million
Q1 2018

May 15, 2018
SELL
$48.49 - $58.14 $3.8 Million - $4.55 Million
-78,320 Reduced 53.79%
67,284 $3.31 Million
Q4 2017

Feb 14, 2018
SELL
$47.53 - $53.73 $127,950 - $144,641
-2,692 Reduced 1.82%
145,604 $7.82 Million
Q3 2017

Nov 14, 2017
SELL
$41.15 - $49.22 $202,704 - $242,457
-4,926 Reduced 3.21%
148,296 $7.14 Million
Q2 2017

Aug 11, 2017
BUY
N/A
153,222
153,222 $6.57 Million

Others Institutions Holding NVO

# of Institutions
1,991
Shares Held
318M
Call Options Held
5.23M
Put Options Held
4.97M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $273B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Fifth Third Bancorp Portfolio

Follow Fifth Third Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email